Analysts expect over 2021 decreasing revenue Biogen

Tomorrow Biogen will publish its past quarters results. For this year Biogen 's (located in Cambridge) revenue will be around 10.87 billion USD. This is according to the average of the analysts' estimates. This is hugely lower than 2021's revenue of 13.44 billion USD.

Historical revenues and results Biogen plus estimates 2021

The analysts expect for 2021 a net profit of 2.87 billion USD. The majority of the analysts expects for this year a profit per share of 19.2 USD. The price/earnings-ratio is then 11.73.

Analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies equals an attractive 2.64 percent.

Biogen 's market capitalization is based on the number of outstanding shares around 39.23 billion USD. -20

Historical stock prices Biogen

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.